The nature of the deposits of conventional pesticide formulations affect their bioavailability and loss. Modification of these formulations and special formulations, in particular microencapsulation, are discussed together with examples. The case for testing of controlled release formulations as part of a biological programme is examined.
No takes yet. Share an insight, caveat, or question.
Marrs et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: